Guidelines For Clinical Practice
Copyright ©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Oncol. Dec 10, 2011; 2(12): 384-396
Published online Dec 10, 2011. doi: 10.5306/wjco.v2.i12.384
IL-6/IL-6R as a potential key signaling pathway in prostate cancer development
Andreia Azevedo, Virginia Cunha, Ana Luisa Teixeira, Rui Medeiros
Andreia Azevedo, Virginia Cunha, Ana Luisa Teixeira, Rui Medeiros, Molecular Oncology and Virology, Portuguese Institute of Oncology, 4200-072 Porto, Portugal
Andreia Azevedo, Rui Medeiros, Research Department of Portuguese League against Cancer (NRNorte), 4200-072 Porto, Portugal
Rui Medeiros, CEBIMED, Faculty of Health Sciences of Fernando Pessoa University, 4200-150 Porto, Portugal
Ana Luisa Teixeira, Rui Medeiros, ICBAS, Abel Salazar Institute for the Biomedical Sciences, University of Porto, 4200-072 Porto, Portugal
Author contributions: Azevedo A and Cunha V designed the structure of the review; Azevedo A wrote the initial draft and the final version of the manuscript; Cunha V, Teixeira AL and Medeiros R critically revised the manuscript for important intellectual content; Medeiros R supervised the study and approved the version to be published.
Supported by Calouste Gulbenkian Foundation (Oncology/2008/Project n 96736) and Science and Technology Foundation (FCT/PTDC/SAU-FCF/71552/2006)
Correspondence to: Rui Medeiros, Professor, Molecular Oncology and Virology, Portuguese Institute of Oncology, Porto, R. Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. ruimedei@ipoporto.min-saude.pt
Telephone: +351-22-5084000 Fax: +351-22-5084001
Received: September 9, 2011
Revised: November 8, 2011
Accepted: November 15, 2011
Published online: December 10, 2011
Core Tip